S. -. Ahn Et Al. , "HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL," EASL International Liver Congress , vol.64, Barcelona, Spain, 2016
Ahn, S. -. Et Al. 2016. HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL. EASL International Liver Congress , (Barcelona, Spain).
Ahn, S. -., Marcellin, P., Ma, X., Caruntu, F., Tak, W. Y., Elkhashab, M., ... Chuang, W. -.(2016). HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL . EASL International Liver Congress, Barcelona, Spain
Ahn, S. Et Al. "HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL," EASL International Liver Congress, Barcelona, Spain, 2016
Ahn, S. -. Et Al. "HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL." EASL International Liver Congress , Barcelona, Spain, 2016
Ahn, S. -. Et Al. (2016) . "HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL." EASL International Liver Congress , Barcelona, Spain.
@conferencepaper{conferencepaper, author={S. -H. Ahn Et Al. }, title={HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL}, congress name={EASL International Liver Congress}, city={Barcelona}, country={Spain}, year={2016}}